Literature DB >> 2533035

Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes.

G Jerums1, T J Allen, M E Cooper.   

Abstract

Two indices of the selectivity of proteinuria, the immunoglobulin G (IgG)/albumin and the IgG/transferrin clearance ratios, were studied cross-sectionally and serially over 7 years in a cohort of 52 Type 1 and 60 Type 2 diabetic patients without established diabetic nephropathy. In Type 1 and Type 2 diabetic patients with albuminuria less than 30 micrograms min-1, both protein clearance ratios were significantly higher than in 27 control subjects. As albuminuria increased, there was a decrease in both protein clearance ratios. However, at albumin clearances above 90 nl s-1, equivalent to albumin excretion rates of greater than 250 micrograms min-1, a positive correlation was found in Type 2 diabetic patients between protein clearance ratios and albuminuria. In individual Type 1 and Type 2 diabetic patients with progressively increasing proteinuria, serial measurements of selectivity showed a decline in both protein clearance ratios with the onset of microalbuminuria. Episodes of transient microalbuminuria were also associated with a fall in the IgG/albumin clearance ratio. The results suggest that the selectivity of proteinuria undergoes a triphasic change with the development of diabetic nephropathy. In the first phase, proteinuria is non-selective with IgG clearance equal to or exceeding transferrin or albumin clearance. As microalbuminuria develops, there is a progressive increase in selectivity reflecting the preferential excretion of transferrin and albumin compared with IgG. In later stages of nephropathy, as shown in Type 2 diabetic patients with macroalbuminuria, there is a return to non-selective proteinuria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533035     DOI: 10.1111/j.1464-5491.1989.tb01277.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  Expression, localization, and function of the thioredoxin system in diabetic nephropathy.

Authors:  Andrew Advani; Richard E Gilbert; Kerri Thai; Renae M Gow; Robyn G Langham; Alison J Cox; Kim A Connelly; Yuan Zhang; Andrew M Herzenberg; Per Knud Christensen; Carol A Pollock; Weier Qi; Sih Min Tan; Hans-Henrik Parving; Darren J Kelly
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

2.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

3.  Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions.

Authors:  Andrew Advani; Darren J Kelly; Suzanne L Advani; Alison J Cox; Kerri Thai; Yuan Zhang; Kathryn E White; Renae M Gow; Sally M Marshall; Brent M Steer; Philip A Marsden; P Elizabeth Rakoczy; Richard E Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

4.  The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction.

Authors:  Suree Lekawanvijit; Sirinart Kumfu; Bing H Wang; Minako Manabe; Fuyuhiko Nishijima; Darren J Kelly; Henry Krum; Andrew R Kompa
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.